article thumbnail

Evaluating methods targeting Protein-Protein Interactions

pharmaphorum

Critical cellular processes including DNA replication and translation cannot occur without functional-specific proteins. It is a popular method in systems biology, requiring fewer compounds to be screened in bioassays, reducing time and cost.

Protein 122
article thumbnail

Reflecting on PEGS Europe 2023 

Drug Discovery World

Next-generation immunotherapies In the session focused on cell-based immunotherapies, Steven Quistad, Senior Applications Scientist, DNA Script, presented on how to rapidly assemble genes in a laboratory using automated enzymatic oligo synthesis. To demonstrate the utility of the company’s SYNTAX system in gene assembly, the 1.7

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Can artificial intelligence help craft new medicines?

Drug Discovery World

Here, new bioassay technologies helped testing, but more definite answers were required. Recombinant DNA technology and improved protein purification techniques further contributed to our understanding and explorations of drug targets. Thus, there was a dire need for new and effective drug targets.

article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

Klaus Wagenbauer, PhD, Founder & CEO, Plectonic, on: ‘Programmable DNA-origami-based T cell engagers: PTE’. Marine Houdou, Genetic Engineering Specialist, Polyplus, on: ‘From modular DNA assembly to recombinant protein production at Polyplus’. The session ends with two presentations and two luncheon presentations.